222

HUMEDIX

No trades
See on Supercharts
Market capitalization
‪344.38 B‬KRW
‪24.82 B‬KRW
‪152.27 B‬KRW
‪5.72 M‬
Beta (1Y)
0.26

About HUMEDIX

CEO
Jin-Hwan Kim
Headquarters
Anyang-si
Employees (FY)
334
Founded
2003
ISIN
KR7200670008
FIGI
BBG007JSTRW6
Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. It offers dermal filler, specialty medicines, ophthalmic solvent, medicine raw materials, and cosmetics. The company was founded on February 27, 2003 and is headquartered in Anyang-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 200670 is 31950 KRW — it has decreased by 2.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HUMEDIX stocks are traded under the ticker 200670.
HUMEDIX is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
200670 stock is 3.31% volatile and has beta coefficient of 0.26. Check out the list of the most volatile stocks — is HUMEDIX there?
HUMEDIX revenue for the last quarter amounts to ‪39.70 B‬ KRW despite the estimated figure of ‪39.55 B‬ KRW. In the next quarter revenue is expected to reach ‪36.70 B‬ KRW.
Yes, you can track HUMEDIX financials in yearly and quarterly reports right on TradingView.
200670 stock has fallen by 2.59% compared to the previous week, the month change is a 6.50% rise, over the last year HUMEDIX has showed a 20.34% increase.
200670 net income for the last quarter is ‪3.25 B‬ KRW, while the quarter before that showed ‪7.21 B‬ KRW of net income which accounts for −55.01% change. Track more HUMEDIX financial stats to get the full picture.
Today HUMEDIX has the market capitalization of ‪335.76 B‬, it has decreased by 0.30% over the last week.
HUMEDIX dividend yield was 1.56% in 2023, and payout ratio reached 20.90%. The year before the numbers were 1.81% and 21.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 200670 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUMEDIX stock right from TradingView charts — choose your broker and connect to your account.
200670 reached its all-time high on Jun 26, 2015 with the price of 88150 KRW, and its all-time low was 10000 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 334.00 employees. See our rating of the largest employees — is HUMEDIX on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUMEDIX technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUMEDIX stock shows the buy signal. See more of HUMEDIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HUMEDIX future price: according to them, 200670 price has a max estimate of 56000.00 KRW and a min estimate of 51000.00 KRW. Read a more detailed HUMEDIX forecast: see what analysts think of HUMEDIX and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUMEDIX EBITDA is ‪48.30 B‬ KRW, and current EBITDA margin is 31.72%. See more stats in HUMEDIX financial statements.